How to improve therapy for adult acute myeloid leukemia: Studies of the AML Cooperative Group in the Federal Republic of Germany
- 1 January 1990
- journal article
- Published by Springer Nature in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 116 (1) , 97-99
- https://doi.org/10.1007/bf01612647
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Maintenance chemotherapy prolongs remission duration in adult acute nonlymphocytic leukemia.Journal of Clinical Oncology, 1988
- COMPARISON OF 3 REMISSION INDUCTION REGIMENS AND 2 POSTINDUCTION STRATEGIES FOR THE TREATMENT OF ACUTE NONLYMPHOCYTIC LEUKEMIA - A CANCER AND LEUKEMIA GROUP-B STUDY1987
- HIGH-DOSE CYTOSINE-ARABINOSIDE AND MITOXANTRONE - A HIGHLY EFFECTIVE REGIMEN IN REFRACTORY ACUTE MYELOID-LEUKEMIA1987
- PRINCIPAL RESULTS OF THE MEDICAL RESEARCH COUNCIL'S 8th ACUTE MYELOID LEUKAEMIA TRIALThe Lancet, 1986
- Intensified induction and consolidation with or without maintenance chemotherapy for acute myeloid leukemia (AML): two multicenter studies of the German AML Cooperative Group.Journal of Clinical Oncology, 1985
- ACUTE MYELOGENOUS LEUKAEMIA: MAINTENANCE CHEMOTHERAPY AFTER EARLY CONSOLIDATION TREATMENT DOES NOT PROLONG SURVIVALThe Lancet, 1984
- A RANDOMIZED STUDY OF THE EFFICACY OF CONSOLIDATION THERAPY IN ADULT ACUTE NONLYMPHOCYTIC LEUKEMIA1984
- A RANDOMIZED COMPARISON OF POSTREMISSION THERAPY IN ACUTE MYELOGENOUS LEUKEMIA - A SOUTHEASTERN CANCER STUDY-GROUP TRIAL1984
- Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB study.1982
- TREATMENT OF ACUTE MYELOCYTIC-LEUKEMIA - A STUDY BY CANCER AND LEUKEMIA GROUP-B1981